Medtronic touts FDA win, commercial launch of next-gen FlexCath sheath

January 16, 2013 by MassDevice staff

Medical device company Medtronic wins FDA clearance for its 2nd-generation FlexCath Advance steerable sheath for use with the Arctic Front Advance cryoablation balloon system.

Medtronic's Arctic Front Advance cryoablation balloon system

Medical device maker Medtronic (NYSE:MDT) this week touted FDA clearance for its next-generation FlexCath Advance steerable sheath, launching U.S. commercial efforts immediately.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp